MENMD Trademark

Trademark Overview


On Wednesday, October 21, 2020, a trademark application was filed for MENMD with the United States Patent and Trademark Office. The USPTO has given the MENMD trademark a serial number of 90975540. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 31, 2022. This trademark is owned by Evitalin. The MENMD trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Dietary and nutritional supplements; Natural supplements for treating erectile dysfunction; Pharmaceutical preparations for the treatment of delayed ejaculation; Pharmaceutical preparations for the treatment of male hypogonadism; Pharmaceutical preparations for the treatment of female dyspareunia; Pharmaceutical preparations for the treatment of overactive bladder; Pharmaceutical preparations for the treatment of prostate health; Pharmaceutical preparations for the treatment of premature ejaculation; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, elixirs for the treatment of prostate cancer; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections

Pharmaceutical compounding services
menmd

General Information


Serial Number90975540
Word MarkMENMD
Filing DateWednesday, October 21, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, May 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements; Natural supplements for treating erectile dysfunction; Pharmaceutical preparations for the treatment of delayed ejaculation; Pharmaceutical preparations for the treatment of male hypogonadism; Pharmaceutical preparations for the treatment of female dyspareunia; Pharmaceutical preparations for the treatment of overactive bladder; Pharmaceutical preparations for the treatment of prostate health; Pharmaceutical preparations for the treatment of premature ejaculation; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, elixirs for the treatment of prostate cancer; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections
Pseudo MarkMEN MD
Goods and ServicesPharmaceutical compounding services
Disclaimer with Predetermined Text"MD"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 9, 2020
Primary Code005
First Use Anywhere DateSaturday, January 1, 2011
First Use In Commerce DateSunday, April 4, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 9, 2020
Primary Code044
First Use Anywhere DateSaturday, January 1, 2011
First Use In Commerce DateSunday, April 4, 2021

Trademark Owner History


Party NameEvitalin
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressClearwater, FL 33760

Trademark Events


Event DateEvent Description
Wednesday, June 1, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, May 31, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, November 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 12, 2021NON-FINAL ACTION E-MAILED
Friday, November 12, 2021NON-FINAL ACTION WRITTEN
Friday, October 15, 2021AMENDMENT TO USE PROCESSING COMPLETE
Thursday, April 22, 2021USE AMENDMENT FILED
Thursday, August 19, 2021DIVISIONAL PROCESSING COMPLETE
Thursday, April 22, 2021DIVISIONAL REQUEST RECEIVED
Monday, August 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 30, 2021RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, July 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 1, 2021ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Thursday, July 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 29, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 28, 2021ASSIGNED TO LIE
Thursday, April 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 22, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, April 22, 2021TEAS AMENDMENT OF USE RECEIVED
Monday, March 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 22, 2021NON-FINAL ACTION E-MAILED
Monday, March 22, 2021NON-FINAL ACTION WRITTEN
Monday, March 22, 2021ASSIGNED TO EXAMINER
Wednesday, December 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 24, 2020NEW APPLICATION ENTERED IN TRAM